CA13
ENSG00000185015
Target class
Enzyme
Chromosome
8
Approved drugs
1
Clinical candidates (approved and in development)
2
- Approved drugs
- 1
- Clinical candidates (approved and in development)
- 2
- Chemical probe available
- No
- Target name
- CA13
- Gene name
- Carbonic anhydrase 13
- Gene symbol
- CA13
- Protein name
- Carbonic anhydrase 13 (EC 4.2.1.1) (Carbonate dehydratase XIII) (Carbonic anhydrase XIII) (CA-XIII)
- CAXIII
- FLJ37995
- MGC59868
- Gene biotype
- Protein coding
- Gene family
- Carbonic anhydrases
- Target class
- Enzyme
- Target type
- Human gene
- Tissues expressed in
- 43
- Protein localisation evidence grade
- Approved
- Highest tissue expression
- 8.39
- Tissue specificity (Gini)
- 0.416
- Tissue specificity (tau)
- 0.707
- KEGG gene identifiers
- hsa:377677
- Reactome pathways
- R-HSA-1475029
- Protein interaction confidence
- 0.854
- Protein interaction partners
- 1
- End position
- 85284073
- Start position
- 85220587
- Chromosome
- 8
- Strand
- Forward
- Nucleoli
- Nucleoplasm
- Vesicles
- Tissue specificity (tau)
- 0.707423
- Expression inequality (Gini)
- 0.415999
Expression in transcripts per million
- Skin - Sun Exposed (Lower leg)
- 8.39
- Skin - Not Sun Exposed (Suprapubic)
- 8.36
- Thyroid
- 8.08
- Minor Salivary Gland
- 7.11
- Esophagus - Mucosa
- 6.41
Expression in transcripts per million
- Skin - Sun Exposed (Lower leg)8.39
- Skin - Not Sun Exposed (Suprapubic)8.36
- Thyroid8.08
- Minor Salivary Gland7.11
- Esophagus - Mucosa6.41
- Small Intestine - Terminal Ileum5.6
- Pituitary5.55
- Vagina4.64
- Stomach4.34
- Lung4.25
- Kidney - Medulla4.1
- Nerve - Tibial3.87
- Cervix - Endocervix3.54
- Colon - Transverse3.13
- Brain - Cerebellar Hemisphere2.92
- Heart - Atrial Appendage2.9
- Kidney - Cortex2.72
- Breast - Mammary Tissue2.65
- Adipose - Visceral (Omentum)2.41
- Cervix - Ectocervix2.38
- Cells - Cultured fibroblasts2.36
- Brain - Cerebellum2.27
- Testis2.23
- Adrenal Gland2.19
- Brain - Frontal Cortex (BA9)2.12
And 29 more, listed on the interactive page.
Cellular components
- GO:0005829
Molecular functions
- GO:0005515
Related records
Trials (4)
- Effect of Sulthiame on EEG in Childhood Epilepsy Syndromes
- Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)
- Pharmacokinetics and Tolerability of Sulthiame
- Population Pharmacokinetics of Antiepileptic in Pediatrics
Drugs (2)
- Ethoxzolamide Carbonic anhydrase inhibitor
- Sulthiame Carbonic anhydrase inhibitor